20-HETE

20-hete is a lipid of Fatty Acyls (FA) class. 20-hete is associated with abnormalities such as Cyst, Kidney Diseases, Kidney Failure, Chronic, Cystic Kidney Diseases and Simple renal cyst. The involved functions are known as Phosphorylation, inhibitors, Hypertrophy, Epithelial Cell Proliferation and Anabolism. 20-hete often locates in Mouse Kidney, Microsomes, Tissue membrane, Body tissue and Cytoplasmic matrix. The associated genes with 20-HETE are CYP4F3 gene, PKHD1 gene, Transgenes, P4HTM gene and CYP2E1 gene. The related lipids are Promega, enterodiol, Fatty Acids, hexanoic acid and U 73343. The related experimental models are Mouse Model, Knock-out, Streptozotocin Diabetes, Transgenic Model and Rodent Model.

References related to locations published in Others

PMID	Journal	Published Date	Author	Title
9770549	Proc. Natl. Acad. Sci. U.S.A.	1998	Muthalif MM et al.	20-Hydroxyeicosatetraenoic acid mediates calcium/calmodulin-dependent protein kinase II-induced mitogen-activated protein kinase activation in vascular smooth muscle cells.
9729509	Am. J. Physiol.	1998	Alonso-Galicia M et al.	Contribution of 20-HETE to the vasodilator actions of nitric oxide in renal arteries.
9688677	Am. J. Physiol.	1998	Su P et al.	Inhibition of renal arachidonic acid omega-hydroxylase activity with ABT reduces blood pressure in the SHR.
10070137	Am. J. Physiol.	1999	Oyekan AO et al.	Endothelin-1 and CYP450 arachidonate metabolites interact to promote tissue injury in DOCA-salt hypertension.
10484476	Am. J. Physiol.	1999	McGiff JC and Quilley J	20-HETE and the kidney: resolution of old problems and new beginnings.
9831701	Circ. Res.	1998	Sun CW et al.	Nitric oxide-20-hydroxyeicosatetraenoic acid interaction in the regulation of K+ channel activity and vascular tone in renal arterioles.
9950890	Am. J. Physiol.	1999	Jacobs ER et al.	Airway synthesis of 20-hydroxyeicosatetraenoic acid: metabolism by cyclooxygenase to a bronchodilator.
9950955	Am. J. Physiol.	1999	Wang MH et al.	Contribution of cytochrome P-450 4A1 and 4A2 to vascular 20-hydroxyeicosatetraenoic acid synthesis in rat kidneys.
11303033	J. Pharmacol. Exp. Ther.	2001	Yaghi A et al.	Cytochrome P450 metabolites of arachidonic acid but not cyclooxygenase-2 metabolites contribute to the pulmonary vascular hyporeactivity in rats with acute Pseudomonas pneumonia.
11320253	Proc. Natl. Acad. Sci. U.S.A.	2001	Holla VR et al.	Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension.
11208597	Am. J. Physiol. Renal Physiol.	2001	Gu R et al.	Role of 20-HETE in mediating the effect of dietary K intake on the apical K channels in the mTAL.
12070222	J. Appl. Physiol.	2002	Zhu D et al.	CYP4A mRNA, protein, and product in rat lungs: novel localization in vascular endothelium.
12060587	Am. J. Physiol. Renal Physiol.	2002	Marji JS et al.	Cytochrome P-450 4A isoform expression and 20-HETE synthesis in renal preglomerular arteries.
12235040	J. Appl. Physiol.	2002	Yu M et al.	Nitric oxide contributes to 20-HETE-induced relaxation of pulmonary arteries.
12419775	Am. J. Physiol. Renal Physiol.	2003	Cheng MK et al.	Renal arterial 20-hydroxyeicosatetraenoic acid levels: regulation by cyclooxygenase.
12794071	J. Biol. Chem.	2003	Basora N et al.	20-hydroxyeicosatetraenoic acid (20-HETE) activates mouse TRPC6 channels expressed in HEK293 cells.
12954811	J. Pharmacol. Exp. Ther.	2003	Quilley J et al.	Inhibitors of 20-hydroxyeicosatetraenoic acid reduce renal vasoconstrictor responsiveness.
12677022	Stroke	2003	Cambj-Sapunar L et al.	Contribution of 5-hydroxytryptamine1B receptors and 20-hydroxyeiscosatetraenoic acid to fall in cerebral blood flow after subarachnoid hemorrhage.
12684227	Am. J. Physiol. Renal Physiol.	2003	Wang MH et al.	Regulation of renal CYP4A expression and 20-HETE synthesis by nitric oxide in pregnant rats.
12754190	Am. J. Physiol. Lung Cell Mol. Physiol.	2003	Cloutier M et al.	20-HETE inotropic effects involve the activation of a nonselective cationic current in airway smooth muscle.
12566369	Circulation	2003	Laffer CL et al.	Differential regulation of natriuresis by 20-hydroxyeicosatetraenoic Acid in human salt-sensitive versus salt-resistant hypertension.
10564244	Am. J. Physiol.	1999	Alonso-Galicia M et al.	20-HETE agonists and antagonists in the renal circulation.
10966934	Am. J. Physiol. Renal Physiol.	2000	Croft KD et al.	Angiotensin II releases 20-HETE from rat renal microvessels.
10992547	Thorax	2000	Carroll MA and McGiff JC	A new class of lipid mediators: cytochrome P450 arachidonate metabolites.
10362756	Am. J. Physiol.	1999	Ito O and Roman RJ	Regulation of P-450 4A activity in the glomerulus of the rat.
10884373	Circ. Res.	2000	Gebremedhin D et al.	Production of 20-HETE and its role in autoregulation of cerebral blood flow.
9618440	J. Pharmacol. Exp. Ther.	1998	Powell PK et al.	Metabolism of arachidonic acid to 20-hydroxy-5,8,11, 14-eicosatetraenoic acid by P450 enzymes in human liver: involvement of CYP4F2 and CYP4A11.
14612451	J. Biol. Chem.	2004	Kaduce TL et al.	20-hydroxyeicosatetraenoic acid (20-HETE) metabolism in coronary endothelial cells.
14634044	J. Pharmacol. Exp. Ther.	2004	Xu F et al.	Catalytic activity and isoform-specific inhibition of rat cytochrome p450 4F enzymes.
15316085	J. Pharmacol. Exp. Ther.	2004	Zhao X et al.	P2X receptor-stimulated calcium responses in preglomerular vascular smooth muscle cells involves 20-hydroxyeicosatetraenoic acid.
15262846	Circulation	2004	Ward NC et al.	Urinary 20-hydroxyeicosatetraenoic acid is associated with endothelial dysfunction in humans.
15075246	Am. J. Physiol. Lung Cell Mol. Physiol.	2004	Fuloria M et al.	20-hydroxyeicosatetraenoic acid is a vasoconstrictor in the newborn piglet pulmonary microcirculation.
21527533	J. Pharmacol. Exp. Ther.	2011	Guo AM et al.	The cytochrome P450 4A/F-20-hydroxyeicosatetraenoic acid system: a regulator of endothelial precursor cells derived from human umbilical cord blood.
20837537	Proc. Natl. Acad. Sci. U.S.A.	2010	Liu JY et al.	Metabolic profiling of murine plasma reveals an unexpected biomarker in rofecoxib-mediated cardiovascular events.
21617146	Stroke	2011	Crago EA et al.	Cerebrospinal fluid 20-HETE is associated with delayed cerebral ischemia and poor outcomes after aneurysmal subarachnoid hemorrhage.
18842817	Am. J. Physiol. Renal Physiol.	2008	Williams JM et al.	Transfer of the CYP4A region of chromosome 5 from Lewis to Dahl S rats attenuates renal injury.
19443836	Circ. Res.	2009	Inoue R et al.	Synergistic activation of vascular TRPC6 channel by receptor and mechanical stimulation via phospholipase C/diacylglycerol and phospholipase A2/omega-hydroxylase/20-HETE pathways.
19570883	Am. J. Physiol. Renal Physiol.	2009	Akbulut T et al.	20-HETE activates the Raf/MEK/ERK pathway in renal epithelial cells through an EGFR- and c-Src-dependent mechanism.
19675180	Am. J. Physiol. Renal Physiol.	2009	Inoue K et al.	Endothelial-specific CYP4A2 overexpression leads to renal injury and hypertension via increased production of 20-HETE.
19841472	J. Pharmacol. Exp. Ther.	2010	Cheng J et al.	20-hydroxy-5,8,11,14-eicosatetraenoic acid mediates endothelial dysfunction via IkappaB kinase-dependent endothelial nitric-oxide synthase uncoupling.
19846914	Anticancer Res.	2009	Alexanian A et al.	Down-regulation of 20-HETE synthesis and signaling inhibits renal adenocarcinoma cell proliferation and tumor growth.
20061439	Am. J. Physiol. Lung Cell Mol. Physiol.	2010	Bodiga S et al.	20-HETE-induced nitric oxide production in pulmonary artery endothelial cells is mediated by NADPH oxidase, H2O2, and PI3-kinase/Akt.
17507602	Am. J. Physiol. Renal Physiol.	2007	Williams JM et al.	Role of endogenous CYP450 metabolites of arachidonic acid in maintaining the glomerular protein permeability barrier.
17660330	Am. J. Physiol. Lung Cell Mol. Physiol.	2007	Morin C et al.	Functional effects of 20-HETE on human bronchi: hyperpolarization and relaxation due to BKCa channel activation.
15821014	Am. J. Physiol. Lung Cell Mol. Physiol.	2005	Parker TA et al.	Inhibition of 20-HETE abolishes the myogenic response during NOS antagonism in the ovine fetal pulmonary circulation.
15831442	J. Pharmacol. Exp. Ther.	2005	Miyata N et al.	Beneficial effects of a new 20-hydroxyeicosatetraenoic acid synthesis inhibitor, TS-011 [N-(3-chloro-4-morpholin-4-yl) phenyl-N'-hydroxyimido formamide], on hemorrhagic and ischemic stroke.
15639488	Cardiovasc. Res.	2005	Randriamboavonjy V et al.	The synthesis of 20-HETE in small porcine coronary arteries antagonizes EDHF-mediated relaxation.
16396943	Am. J. Physiol. Renal Physiol.	2006	Roman RJ et al.	Characterization of blood pressure and renal function in chromosome 5 congenic strains of Dahl S rats.
16339392	J. Pharmacol. Exp. Ther.	2006	Zhou Y et al.	Induction of renal 20-hydroxyeicosatetraenoic acid by clofibrate attenuates high-fat diet-induced hypertension in rats.
15531567	J. Appl. Physiol.	2005	Baines AD and Ho P	20-HETE-mediated vasoconstriction by hemoglobin-O2 carrier in Sprague-Dawley but not Wistar rats.
15499026	Circ. Res.	2004	Scotland RS et al.	Vanilloid receptor TRPV1, sensory C-fibers, and vascular autoregulation: a novel mechanism involved in myogenic constriction.
16081420	J. Biol. Chem.	2005	Collins XH et al.	Omega-oxidation of 20-hydroxyeicosatetraenoic acid (20-HETE) in cerebral microvascular smooth muscle and endothelium by alcohol dehydrogenase 4.
16081682	J. Pharmacol. Exp. Ther.	2005	Guo M et al.	Human U251 glioma cell proliferation is suppressed by HET0016 [N-hydroxy-N'-(4-butyl-2-methylphenyl)formamidine], a selective inhibitor of CYP4A.
16055480	Am. J. Physiol. Lung Cell Mol. Physiol.	2005	Yaghi A and Sims SM	Constrictor-induced translocation of NFAT3 in human and rat pulmonary artery smooth muscle.
15998843	Am. J. Physiol. Renal Physiol.	2005	Huang H et al.	Renal 20-HETE inhibition attenuates changes in renal hemodynamics induced by L-NAME treatment in pregnant rats.
16543501	Circ. Res.	2006	Wang JS et al.	Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus.
16614311	Circ. Res.	2006	Harder DR and Roman RJ	Endothelial dysfunction and hypertension in rats transduced with CYP4A2 adenovirus.
16775295	AJNR Am J Neuroradiol	2006 Jun-Jul	Hacein-Bey L et al.	Reversal of delayed vasospasm by TS-011 in the dual hemorrhage dog model of subarachnoid hemorrhage.
16679377	Am. J. Physiol. Lung Cell Mol. Physiol.	2006	Chen Y et al.	Mechanisms of activation of eNOS by 20-HETE and VEGF in bovine pulmonary artery endothelial cells.
16679379	Am. J. Physiol. Lung Cell Mol. Physiol.	2006	Jacobs ER et al.	VEGF-induced relaxation of pulmonary arteries is mediated by endothelial cytochrome P-450 hydroxylase.
16166237	J. Appl. Physiol.	2006	Qin X et al.	Role of 20-HETE in the pial arteriolar constrictor response to decreased hematocrit after exchange transfusion of cell-free polymeric hemoglobin.
17210799	J. Pharmacol. Exp. Ther.	2007	Guo AM et al.	Activation of vascular endothelial growth factor through reactive oxygen species mediates 20-hydroxyeicosatetraenoic acid-induced endothelial cell proliferation.
18596124	J. Am. Soc. Nephrol.	2008	Park F et al.	20-HETE mediates proliferation of renal epithelial cells in polycystic kidney disease.
18725506	Drug Metab. Dispos.	2008	Mu Y et al.	Intravenous formulation of N-hydroxy-N'-(4-n-butyl-2-methylphenyl)formamidine (HET0016) for inhibition of rat brain 20-hydroxyeicosatetraenoic acid formation.
17916879	J. Lipid Res.	2008	Liang CJ et al.	20-HETE inhibits the proliferation of vascular smooth muscle cells via transforming growth factor-beta.
22723444	Arterioscler. Thromb. Vasc. Biol.	2012	Cheng J et al.	Induction of angiotensin-converting enzyme and activation of the renin-angiotensin system contribute to 20-hydroxyeicosatetraenoic acid-mediated endothelial dysfunction.
22798501	Cancer Genomics Proteomics	2012 Jul-Aug	Alexanian A et al.	20-HETE-producing enzymes are up-regulated in human cancers.
23641057	J. Am. Soc. Nephrol.	2013	Wu CC et al.	Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase.
23658377	J. Pharmacol. Exp. Ther.	2013	Orozco LD et al.	20-Hydroxyeicosatetraenoic acid inhibition attenuates balloon injury-induced neointima formation and vascular remodeling in rat carotid arteries.
23392684	J. Neurosci.	2013	Fordsmann JC et al.	Increased 20-HETE synthesis explains reduced cerebral blood flow but not impaired neurovascular coupling after cortical spreading depression in rat cerebral cortex.
23382413	Am. J. Hypertens.	2013	Jiang H et al.	Maternal and fetal epoxyeicosatrienoic acids in normotensive and preeclamptic pregnancies.
23966667	J. Lipid Res.	2013	Van Bogaert I et al.	Preparation of 20-HETE using multifunctional enzyme type 2-negative Starmerella bombicola.
25792716	J. Appl. Physiol.	2015	Liu X et al.	Contribution of epoxyeicosatrienoic acids to the cerebral blood flow response to hypoxemia.
24990891	Am. J. Physiol. Renal Physiol.	2014	Ren Y et al.	Mechanism of impaired afferent arteriole myogenic response in Dahl salt-sensitive rats: role of 20-HETE.
26895643	Am. J. Physiol. Lung Cell Mol. Physiol.	2016	Kizub IV et al.	Involvement of gap junctions between smooth muscle cells in sustained hypoxic pulmonary vasoconstriction development: a potential role for 15-HETE and 20-HETE.
28039371	J. Neurosci.	2017	Mapelli L et al.	Granular Layer Neurons Control Cerebellar Neurovascular Coupling Through an NMDA Receptor/NO-Dependent System.
27559173	J. Neurosci.	2016	Ziegler N et al.	β-Catenin Is Required for Endothelial Cyp1b1 Regulation Influencing Metabolic Barrier Function.
27528620	Mol. Cell. Biol.	2016	Garbacz WG et al.	Hepatic Overexpression of CD36 Improves Glycogen Homeostasis and Attenuates High-Fat Diet-Induced Hepatic Steatosis and Insulin Resistance.
27194719	Am. J. Physiol. Renal Physiol.	2016	Dalmasso C et al.	20-HETE and CYP4A2 ω-hydroxylase contribute to the elevated blood pressure in hyperandrogenemic female rats.
27084395	Vascul. Pharmacol.	2016	Chen L et al.	20-HETE contributes to ischemia-induced angiogenesis.
26747234	Prostaglandins Other Lipid Mediat.	2016	Huang H et al.	Cyclooxygenase- and cytochrome P450-derived eicosanoids in stroke.
26699146	J. Pharmacol. Exp. Ther.	2016	Garcia V et al.	20-HETE Activates the Transcription of Angiotensin-Converting Enzyme via Nuclear Factor-κB Translocation and Promoter Binding.
25908301	Prostaglandins Other Lipid Mediat.	2015	Vanella L et al.	Soluble epoxide hydrolase null mice exhibit female and male differences in regulation of vascular homeostasis.
25813407	Prostaglandins Other Lipid Mediat.	2015	Hoopes SL et al.	Vascular actions of 20-HETE.
25644108	J. Am. Soc. Nephrol.	2015	Muroya Y et al.	Deficiency in the Formation of 20-Hydroxyeicosatetraenoic Acid Enhances Renal Ischemia-Reperfusion Injury.
25447342	Prostaglandins Other Lipid Mediat.	2015 Jan-Mar	McCarthy ET et al.	Ethanol at low concentrations protects glomerular podocytes through alcohol dehydrogenase and 20-HETE.
25249502	J. Lipid Res.	2014	Jarrar YB et al.	Determination of major UDP-glucuronosyltransferase enzymes and their genotypes responsible for 20-HETE glucuronidation.
25071086	J. Am. Soc. Nephrol.	2015	Gangadhariah MH et al.	Hypertension is a major contributor to 20-hydroxyeicosatetraenoic acid-mediated kidney injury in diabetic nephropathy.
25007877	Am. J. Physiol. Renal Physiol.	2014	Ge Y et al.	Role of 20-HETE in the impaired myogenic and TGF responses of the Af-Art of Dahl salt-sensitive rats.